17 December, 2019

“We want to hand over the tools, thoughts, reflections & methods to take the EU forward over the next 10 years.”

Oliver Kacelnik, from the Norwegian Institute of Public Health, and Antonio López Navas, from the Spanish Agency of Medicines and Medical Devices, talk about their work to ensure the appropriate use of antimicrobials in humans and animals, as well as their expectations of the Joint Action.
12 December, 2019

“EUJAMRAI legacy will include awareness of using systematic implementation & continuous quality improvement.”

Lotta Edman, from the Public Health Agency of Sweden, and Flora Kontopidou, from the Hellenic Centrefor Disease control and Prevention, tell us about their work reviewing, developing and implemeting policies for prevention of Healthcare-Associated Infections.
10 December, 2019

“The legacy of EU-JAMRAI will be a big network with a real commitment to AMR.”

Desiree De Jong, from the Dutch Ministry of Health, Welfare and Sport, talks about their role implementing One Health national action plans for AMR, as well as her personal expectations for EU-JAMRAI.
5 December, 2019

“Working in networks & sharing experiences will become natural for #EUJAMRAI stakeholders & member states.”

Céline Pulcini and Jerome Weinbach, from the French Ministry of Social Affairs and Health, tell us about what they do at EU-JAMRAI Sustainability Team and the role of the Joint Action's Stakeholder Forum.
3 December, 2019

“It is only by collaborating, discussing & confronting experiences and best practices that we can tackle #AMR.”

Annalisa Pantosti, from the Italian National Institute of Health, tell us about the role of the Evaluation team as well as their experience organising EU-JAMRAI's second General Assembly.
27 November, 2019

“When we do something ourselves, we appropriate it and we can change behaviour.”

Laura Alonso Irujo and Ángela Monasor Pascual, from the Spanish Agency of Medicines and Medical Devices, talk about their role at EU-JAMRAI's Communication Team, their contribution to our second General Assembly, and where they think EU-JAMRAI will be within a year.
27 November, 2019

“We need to continue this synergy between the different actors to go one step beyond.”

Marie Céclie Ploy  and Sadika Bernard, both working at the French National Institute of Health and Medical Research, talk about what they do at EU-JAMRAI's Coordination Team, their contribution to the Joint Action's second General Assembly, and where they see EU-JAMRAI in one year's time.
5 November, 2019

“We want to see the fruits of EU-JAMRAI spreading a culture of good practice.”

Dr Charles Price, DG SANTE, European Commission, talks about the relevance of the global challenge of AMR in the EU Health Programme, and the role of EU-JAMRAI to tackle this issue.
9 May, 2019

“EU-JAMRAI gathers all European member states & stakeholders involved in AMR”

EU-JAMRAI Coordinator Professor Marie-Cécile Ploy talks to bioMérieux during ECCMID 2019 and explains what the Joint Action is exactly and its objectives. EU-JAMRAI gathers all European […]
18 March, 2019

“It is important to explain to policy makers that AMR threatens global prosperity”

Jeremy Knox, policy and advocacy lead at the Wellcome Trust, chats with EU-JAMRAI about how we rely on antibiotics for treatments that we take for granted, the […]
3 December, 2018

“Animal health and environment are crucial and critical, and we need to put more effort on that”

Laura Marín is Head of Secretariat of the jpiamr project
3 September, 2018

“Antibiotics have been very easy to use and very easy to abuse”

Richard Bax is Senior Partner of TranScrip. He is a Pharmaceutical Physician with over 32 years of industry experience and expert in Infectious Diseases. “Antibiotics have […]
Previous Next
Test Caption
Test Description goes like this